HTB homepage • Conference reports • Articles by subject • Subscribe May 2014 Contents Editorial May/June 2014: Volume 15 Number 5/6 Conference reports 49th Annual Meeting of the European Association for the Study of the Liver (EASL 2014), 9-13 April 2014, London Activists protest the price of sofosbuvir: “So-Valdi, So-Expensive” – UK access already rationed EASL 2014: summary of interferon-free HCV studies with new DAAs WHO launch treatment guidelines for hepatitis C (2014) 3rd Joint Conference of BHIVA/BASHH, 1-4 April 2014, Liverpool 50% of UK seroconverters start ART within 1.4 years of infection: treating during primary infection should be a patient choice PIVOT study: further analysis from five-year PI/r monotherapy strategy study Sexually transmitted HCV in HIV positive and negative gay men Annual HCV testing and use of core antigen to reduce costs and increase diagnosis during acute HCV HIV positive attitudes to involvement as donors and recipients in organ transplant programmes 21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston Pharmacokinetics of antiretrovirals in pregnancy Better virologic outcomes with efavirenz vs lopinavir/ritonavir in pregnant women and no difference in risk of preterm birth Once daily lopinavir/ritonavir not recommended for routine use in children and adolescents Early antiretroviral treatment in infants Hospitalisation among elite controllers Catching up with pathogenesis and cure research from CROI 2014 Guidelines US adult treatment guidelines updated (May 2014) US PrEP guidelines (May 2014): emphasis on broad access may miss optimal use by people at highest risk Side effects No increase death rate in HIV positive people with renal dysfunction receiving tenofovir in Zambia Hepatitis coinfection EMA fast-track sofosbuvir/ledipasvir FDC for hepatitis C Cure-related research Reassessing the role of HDAC inhibitors in cure research More on the links between the CD4/CD8 ratio, immunological perturbations, and risk of illness and death Basic science and immunology Incidence of HIV dual infections in US men who have sex with men Other news Partner 2 study extended for gay couples TAILoR Study: telmisartan to reduce risk of insulin resistance: potential role for lipodystrophy SCART study: selumetinib as potential treatment for HIV-related KS Scotland agrees to free HIV treatment, regardless of residency status On the web Community reports and briefings PDFs Volume 15 Number 5/6 May/June 2014 PDF HTB homepage • Conference reports • Articles by subject • Subscribe